WKSWA
White Knight Strategic Wealth Advisors Portfolio holdings
AUM
$118M
1-Year Return
28.25%
This Quarter Return
-3.79%
1 Year Return
+28.25%
3 Year Return
+111.52%
5 Year Return
–
10 Year Return
–
AUM
$69.9M
AUM Growth
-$2.53M
(-3.5%)
Cap. Flow
+$575K
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
54.06%
Holding
67
New
4
Increased
25
Reduced
25
Closed
5
Top Buys
| 1 |
Pfizer
PFE
|
$580K |
| 2 |
ARK Innovation ETF
ARKK
|
$520K |
| 3 |
Abbott
ABT
|
$369K |
| 4 |
Moderna
MRNA
|
$264K |
| 5 |
Netflix
NFLX
|
$235K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$566K |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$309K |
| 3 |
Salesforce
CRM
|
$229K |
| 4 |
Blackrock
BLK
|
$220K |
| 5 |
Invesco QQQ Trust
QQQ
|
$200K |
Sector Composition
| 1 | Financials | 22.44% |
| 2 | Technology | 14.32% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Healthcare | 11.64% |
| 5 | Communication Services | 6.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Qualcomm
QCOM
$170B
| $278K | 0.4% |
2,458
+65
| +3% | +$7.35K |
|
|
52
Moderna
MRNA
$9.3B
| $264K | 0.38% |
+2,234
| New | +$264K |
|
53
iShares S&P Small-Cap 600 Growth ETF
IJT
$6.25B
| $251K | 0.36% |
2,466
-115
| -4% | -$11.7K |
|
54
Edwards Lifesciences
EW
$47.7B
| $250K | 0.36% |
3,026
+50
| +2% | +$4.13K |
|
55
Vanguard S&P 500 ETF
VOO
$727B
| $246K | 0.35% |
748
| – | – |
|
|
56
Netflix
NFLX
$533B
| $235K | 0.34% |
+997
| New | +$235K |
|
57
Electronic Arts
EA
$41.7B
| $229K | 0.33% |
1,980
-115
| -5% | -$13.3K |
|
58
Innovator Growth Accelerated Plus ETF January
QTJA
$21.2M
| $216K | 0.31% |
12,763
-462
| -3% | -$7.82K |
|
59
Advanced Micro Devices
AMD
$260B
| $208K | 0.3% |
3,287
+91
| +3% | +$5.76K |
|
|
BGX
60
Blackstone Long-Short Credit Income Fund
BGX
$158M
| $208K | 0.3% |
19,103
+41
| +0.2% | +$446 |
|
61
Icon
ICLR
$13.7B
| $208K | 0.3% |
1,130
| – | – |
|
62
Palantir
PLTR
$365B
| $95K | 0.14% |
11,710
+410
| +4% | +$3.33K |
|
|
63
Blackrock
BLK
$171B
| – | – |
-361
| Closed | -$220K |
|
|
64
Bristol-Myers Squibb
BMY
$95.2B
| – | – |
-7,347
| Closed | -$566K |
|
|
65
Salesforce
CRM
$231B
| – | – |
-1,386
| Closed | -$229K |
|
|
66
Invesco QQQ Trust
QQQ
$366B
| – | – |
-715
| Closed | -$200K |
|
|
67
Regeneron Pharmaceuticals
REGN
$60B
| – | – |
-522
| Closed | -$309K |
|